Test Bank: Pharmacotherapeutics for Advanced
wz z z z
Practice Nurse Prescribers, 5th Edition, Teri Moser
z z z wz z z z
Woo, Marylou
z wz
Pharmacotherapeutics for w
AdvancedPractice Nurse Prescribers 5th
w w w w w
EditionWoo Robinson Test Bank
w w w w
,Test Bank: Pharmacotherapeutics for Advanced
wz z z z
Practice Nurse Prescribers,
wz z z
5th Edition, Teri Moser Woo, Marylou
wz z z z wz wz
Pharmacotherapeutics wfor wAdvanced wPractice wNurse wPrescribers w5th wEdition wWoo
wRobinson wTestwBank
Chapter w1. wThe wRole wof wthe wNurse
wPractitionerMultiple w Choice
Identify w the w choice w that w best w completes w the w statement w or w answers w the w question.
w 1. w Nurse w practitioner w prescriptive w authority w is w regulated wby:
1. The w National w Council w of w State w Boards w of w Nursing
2. The w U.S. w Drug w Enforcement w Administration
3. The w State w Board w of w Nursing w for w each w state
4. The w State w Board w of w Pharmacy
w 2. w The w benefits w to w the w patient w of w having w an w Advanced wzPractice w Registered
w Nurse w (APRN)wprescriberinclude:
1. Nurses w know w more w about w Pharmacology w than w other w prescribers
wzbecause w theywtake w itboth w in w their w basic w nursing w program w and
w in wztheir w APRN wzprogram.
2. Nurses w care w for w the w patient w from w a wzholistic wzapproach wzand
w include w thewpatient w indecision w making w regarding w their wzcare.
3. APRNs w are w less w likely w to w prescribe wznarcotics wzand wzother wzcontrolled w substances.
4. APRNs ware wable wto wprescribe windependently win wall wzstates, wwhereas wa
wphysician’sassistant w needs w to w have w a w physician w supervising
w their w practice.
w 3. w Clinical w judgment w in wzprescribing w includes:
1. Factoring w in w the wzcost wzto wzthe w patient wzof w the w medication w prescribed
2. Always w prescribing w the wznewest w medication w available w for w the w disease w process
3. Handing w out wzdrug wzsamples wzto w poor w patients
4. Prescribing w all wzgeneric w medications w to w cut w costs
w 4. w Criteria w for wzchoosing wzan wzeffective wzdrug w for w a w disorder w include:
1. Asking w the wzpatient w what wzdrug w they w think w would w work w best w for w them
2. Consulting w nationally w recognized w guidelines w for w disease w management
3. Prescribing w medications wzthat w are w available w as w samples w before w writing w a
w prescription
4. Following w U.S. wzDrug w Enforcement w Administration w guidelines w for w prescribing
z wz w 5. w Nurse w practitioner wzpractice w may w thrive w under w health-care w reform w because w of:
1. The w demonstrated w ability w of w nurse w practitioners w to w control w costs
w and w improvewpatientoutcomes
2. The w fact w that w nurse w practitioners w will w be w able w to w practice w independently
3. The wzfact w that w nurse w practitioners w will w have w full
w reimbursement w underwhealth-carereform
4. The w ability w to w shift w accountability w for w Medicaid w to w the w state w level
,Test Bank: Pharmacotherapeutics for Advanced
wz z z z
Practice Nurse Prescribers,
wz z z
5th Edition, Teri Moser Woo, Marylou
wz z z z wz wz
, Test Bank: Pharmacotherapeutics for Advanced
wz z z z
Practice Nurse Prescribers,
wz z z
5th Edition, Teri Moser Woo, Marylou
wz z z z wz wz
Chapter w1. wThe wRole wof wthe wNurse
wPractitionerAnswer w Section
MULTIPLE w CHOICE
1. wANS: 3 PTS: 1
2. wANS: 2 PTS: 1
3. wANS: 1 PTS: 1
4. wANS: 2 PTS: 1
5. wANS: 1 PTS: 1
Chapter w 2. w Review w of w Basic w Principles w of
PharmacologyMultiple w Choice
Identify w the w choice w that w best w completes w the w statement w or w answers w the w question.
w 1. wA w patient’s w nutritional w
intake w and w laboratory w results w reflect
wzhypoalbuminemia. w This w iswcritical w toprescribing w because:
1. Distribution w of w drugs w to w target w tissue w may wzbe w affected.
2. The w solubility w of w the w drug w will wznot wzmatch wzthe wzsite w of wzabsorption.
3. There w will w be w less w free w drug w available wzto wzgenerate wzan wzeffect.
4. Drugs w bound w to w albumin w are w readily w excreted w by wzthe w kidneys.
w 2. w Drugs w that w have w a w significant wzfirst-pass wzeffect:
1. Must w be w given w by wzthe wzenteral w (oral) wzroute w only
2. Bypass w the w hepatic w circulation
3. Are w rapidly wzmetabolized wzby wzthe w liver w and w may w have w little w if w any w desired w action
4. Are w converted wzby w the w liver wzto wzmore w active w and w fat-soluble w forms
w 3. w The w route wzof w excretion wzof w a w volatile w drug w will w likely w be w the:
1. Kidneys
2. Lungs
3. Bile w and wzfeces
4. Skin
z 4. wMedroxyprogesterone w(Depo wProvera) wis wprescribed wintramuscularly w(IM) wto
wcreate wawstoragereservoir wzof w the w drug. w Storage w reservoirs:
1. Assure w that wzthe w drug w will w reach w its w intended w target w tissue
2. Are w the w reason w for w giving w loading w doses
3. Increase w the w length w of w time w a w drug w is w available w and w active
4. Are w most w common w in w collagen w tissues
w 5. w The w NP w chooses w to w give w cephalexin w every w 8 w hours w based w on w knowledge w of
w the w drug’s:
1. Propensity w to w go w to w the w target w receptor
2. Biological w half-life
3. Pharmacodynamics
4. Safety w and w side w effects
wz z z z
Practice Nurse Prescribers, 5th Edition, Teri Moser
z z z wz z z z
Woo, Marylou
z wz
Pharmacotherapeutics for w
AdvancedPractice Nurse Prescribers 5th
w w w w w
EditionWoo Robinson Test Bank
w w w w
,Test Bank: Pharmacotherapeutics for Advanced
wz z z z
Practice Nurse Prescribers,
wz z z
5th Edition, Teri Moser Woo, Marylou
wz z z z wz wz
Pharmacotherapeutics wfor wAdvanced wPractice wNurse wPrescribers w5th wEdition wWoo
wRobinson wTestwBank
Chapter w1. wThe wRole wof wthe wNurse
wPractitionerMultiple w Choice
Identify w the w choice w that w best w completes w the w statement w or w answers w the w question.
w 1. w Nurse w practitioner w prescriptive w authority w is w regulated wby:
1. The w National w Council w of w State w Boards w of w Nursing
2. The w U.S. w Drug w Enforcement w Administration
3. The w State w Board w of w Nursing w for w each w state
4. The w State w Board w of w Pharmacy
w 2. w The w benefits w to w the w patient w of w having w an w Advanced wzPractice w Registered
w Nurse w (APRN)wprescriberinclude:
1. Nurses w know w more w about w Pharmacology w than w other w prescribers
wzbecause w theywtake w itboth w in w their w basic w nursing w program w and
w in wztheir w APRN wzprogram.
2. Nurses w care w for w the w patient w from w a wzholistic wzapproach wzand
w include w thewpatient w indecision w making w regarding w their wzcare.
3. APRNs w are w less w likely w to w prescribe wznarcotics wzand wzother wzcontrolled w substances.
4. APRNs ware wable wto wprescribe windependently win wall wzstates, wwhereas wa
wphysician’sassistant w needs w to w have w a w physician w supervising
w their w practice.
w 3. w Clinical w judgment w in wzprescribing w includes:
1. Factoring w in w the wzcost wzto wzthe w patient wzof w the w medication w prescribed
2. Always w prescribing w the wznewest w medication w available w for w the w disease w process
3. Handing w out wzdrug wzsamples wzto w poor w patients
4. Prescribing w all wzgeneric w medications w to w cut w costs
w 4. w Criteria w for wzchoosing wzan wzeffective wzdrug w for w a w disorder w include:
1. Asking w the wzpatient w what wzdrug w they w think w would w work w best w for w them
2. Consulting w nationally w recognized w guidelines w for w disease w management
3. Prescribing w medications wzthat w are w available w as w samples w before w writing w a
w prescription
4. Following w U.S. wzDrug w Enforcement w Administration w guidelines w for w prescribing
z wz w 5. w Nurse w practitioner wzpractice w may w thrive w under w health-care w reform w because w of:
1. The w demonstrated w ability w of w nurse w practitioners w to w control w costs
w and w improvewpatientoutcomes
2. The w fact w that w nurse w practitioners w will w be w able w to w practice w independently
3. The wzfact w that w nurse w practitioners w will w have w full
w reimbursement w underwhealth-carereform
4. The w ability w to w shift w accountability w for w Medicaid w to w the w state w level
,Test Bank: Pharmacotherapeutics for Advanced
wz z z z
Practice Nurse Prescribers,
wz z z
5th Edition, Teri Moser Woo, Marylou
wz z z z wz wz
, Test Bank: Pharmacotherapeutics for Advanced
wz z z z
Practice Nurse Prescribers,
wz z z
5th Edition, Teri Moser Woo, Marylou
wz z z z wz wz
Chapter w1. wThe wRole wof wthe wNurse
wPractitionerAnswer w Section
MULTIPLE w CHOICE
1. wANS: 3 PTS: 1
2. wANS: 2 PTS: 1
3. wANS: 1 PTS: 1
4. wANS: 2 PTS: 1
5. wANS: 1 PTS: 1
Chapter w 2. w Review w of w Basic w Principles w of
PharmacologyMultiple w Choice
Identify w the w choice w that w best w completes w the w statement w or w answers w the w question.
w 1. wA w patient’s w nutritional w
intake w and w laboratory w results w reflect
wzhypoalbuminemia. w This w iswcritical w toprescribing w because:
1. Distribution w of w drugs w to w target w tissue w may wzbe w affected.
2. The w solubility w of w the w drug w will wznot wzmatch wzthe wzsite w of wzabsorption.
3. There w will w be w less w free w drug w available wzto wzgenerate wzan wzeffect.
4. Drugs w bound w to w albumin w are w readily w excreted w by wzthe w kidneys.
w 2. w Drugs w that w have w a w significant wzfirst-pass wzeffect:
1. Must w be w given w by wzthe wzenteral w (oral) wzroute w only
2. Bypass w the w hepatic w circulation
3. Are w rapidly wzmetabolized wzby wzthe w liver w and w may w have w little w if w any w desired w action
4. Are w converted wzby w the w liver wzto wzmore w active w and w fat-soluble w forms
w 3. w The w route wzof w excretion wzof w a w volatile w drug w will w likely w be w the:
1. Kidneys
2. Lungs
3. Bile w and wzfeces
4. Skin
z 4. wMedroxyprogesterone w(Depo wProvera) wis wprescribed wintramuscularly w(IM) wto
wcreate wawstoragereservoir wzof w the w drug. w Storage w reservoirs:
1. Assure w that wzthe w drug w will w reach w its w intended w target w tissue
2. Are w the w reason w for w giving w loading w doses
3. Increase w the w length w of w time w a w drug w is w available w and w active
4. Are w most w common w in w collagen w tissues
w 5. w The w NP w chooses w to w give w cephalexin w every w 8 w hours w based w on w knowledge w of
w the w drug’s:
1. Propensity w to w go w to w the w target w receptor
2. Biological w half-life
3. Pharmacodynamics
4. Safety w and w side w effects
